Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jackson Sillah is active.

Publication


Featured researches published by Jackson Sillah.


Nature Genetics | 2007

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.

Chiea C. Khor; Stephen Chapman; Fredrik O. Vannberg; Aisling Dunne; Caroline Murphy; Edmund Y. S. Ling; Angela J. Frodsham; Andrew Walley; Otto Kyrieleis; Amir R. Khan; Christophe Aucan; Shelley Segal; Catrin E. Moore; Kyle Knox; S J Campbell; Christian Lienhardt; Anthony Scott; Peter Aaby; Oumou Sow; Robert T Grignani; Jackson Sillah; Giorgio Sirugo; N. Peshu; Thomas N. Williams; Kathryn Maitland; Robert J. O. Davies; Dominic P. Kwiatkowski; Nicholas P. J. Day; Djamel Yala; Derrick W. Crook

Toll-like receptors (TLRs) and members of their signaling pathway are important in the initiation of the innate immune response to a wide variety of pathogens. The adaptor protein Mal (also known as TIRAP), encoded by TIRAP (MIM 606252), mediates downstream signaling of TLR2 and TLR4 (refs. 4–6). We report a case-control study of 6,106 individuals from the UK, Vietnam and several African countries with invasive pneumococcal disease, bacteremia, malaria and tuberculosis. We genotyped 33 SNPs, including rs8177374, which encodes a leucine substitution at Ser180 of Mal. We found that heterozygous carriage of this variant associated independently with all four infectious diseases in the different study populations. Combining the study groups, we found substantial support for a protective effect of S180L heterozygosity against these infectious diseases (N = 6,106; overall P = 9.6 × 10−8). We found that the Mal S180L variant attenuated TLR2 signal transduction.


European Journal of Immunology | 2002

Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo

Christian Lienhardt; Annalisa Azzurri; Amedeo Amedei; Katherine Fielding; Jackson Sillah; Oumou Sow; Boubacar Bah; Marisa Benagiano; Alimou Diallo; Roberto Manetti; Kebba Manneh; Per Gustafson; Steve Bennett; Mario M. D'Elios; Keith P. W. J. McAdam; Gianfranco Del Prete

Activation of Th1 lymphocytes, IFN‐γ production and macrophage activation are crucial in defense against Mycobacteria. In developing countries, Th2 activation and IL‐4 production have been associated in vitro with tuberculosis and with poor clinical outcome after treatment. Serological markers of Th1 [soluble lymphocyte activation gene (LAG)‐3] and Th2 (IgE, solubleCD30, and CCL22/macrophage‐derived chemokine) activity were measured in 414 HIV‐negative tuberculosis patients from The Gambia and Guinée and in 414 healthy household and community controls. Measurements were repeated during treatment to assess the effect of therapy on Th1/Th2 ratio. At diagnosis, sLAG‐3 levels were lower in patients than in community controls (p<0.0001), but were higher in household controls exposed to contact with patients than in community controls (p<0.0001). In comparison with community controls, patients had consistently higher levels of IgE, sCD30, and CCL22 (p<0.0001), whereas household controls had lower levels of indicators of Th2 activity (p<0.0001). After treatment, cured patients had higher levels of Th1 (p<0.0001) and lower levels of Th2 (p<0.0001) activity than patients who were not successfully treated or interrupted therapy. In Africa, tuberculosis is associated with low Th1 and high Th2 activity in vivo, whereas close exposure to tuberculosis is associated with a high Th1/Th2 ratio. Patients with favorable outcome after treatment exhibit a higher Th1/Th2 ratio compared to patients with poor clinical outcome.


The Journal of Infectious Diseases | 2004

Vitamin D Receptor Polymorphisms and Susceptibility to Tuberculosis in West Africa: A Case-Control and Family Study

Liza Bornman; S J Campbell; Katherine Fielding; Boubacar Bah; Jackson Sillah; Per Gustafson; Kebba Manneh; Ida Maria Lisse; Angela Allen; Giorgio Sirugo; Aissatou Sylla; Peter Aaby; K.P.W.J. McAdam; Oumou Bah-Sow; Steve Bennett; Christian Lienhardt; Adrian V. S. Hill

Vitamin D receptor (VDR) gene polymorphisms have been implicated in susceptibility to tuberculosis (TB), but reports have been inconsistent. We genotyped the VDR single-nucleotide polymorphisms (SNPs) FokI, BsmI, ApaI, and TaqI in 1139 case patients and control subjects and 382 families from The Gambia, Guinea, and Guinea-Bissau. The transmission-disequilibrium test on family data showed a significant global association of TB with SNP combinations FokI-BsmI-ApaI-TaqI and FokI-ApaI that were driven by the increased transmission to affected offspring of the FokI F and ApaI A alleles in combination. The ApaI A allele was also transmitted to affected offspring significantly more often than expected. Case-control analysis showed no statistically significant association between TB and VDR variants. BsmI, ApaI, and TaqI showed strong linkage disequilibrium. The significance of the family-based associations found between TB and FokI-BsmI-ApaI-TaqI and the FA haplotype supports a role for VDR haplotypes, rather than individual genotypes, in susceptibility to TB.


Infection and Immunity | 2001

Tuberculosis Contacts but Not Patients Have Higher Gamma Interferon Responses to ESAT-6 than Do Community Controls in The Gambia

Johan Vekemans; Christian Lienhardt; Jackson Sillah; Jeremy Wheeler; George Lahai; Mark Doherty; Tumani Corrah; Peter Andersen; Keith P. W. J. McAdam; Arnaud Marchant

ABSTRACT The Mycobacterium tuberculosis antigen ESAT-6 has been proposed for tuberculosis immunodiagnosis. In The Gambia, 30% of community controls produced gamma interferon (IFN-γ) in response to ESAT-6. Increased proportions of responders and intensities of responses were found in household contacts. Responses that were initially low in tuberculosis patients increased after treatment. An ESAT-6 IFN-γ assay will be of limited use in the diagnosis of tuberculosis in countries where tuberculosis is endemic. Its role in contact tracing should be evaluated further.


Proceedings of the National Academy of Sciences of the United States of America | 2006

Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa.

Kerrie Tosh; S J Campbell; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; Kebba Manneh; Ida Maria Lisse; Giorgio Sirugo; Steve Bennett; Peter Aaby; Keith P. W. J. McAdam; Oumou Bah-Sow; Christian Lienhardt; Igor Kramnik; Adrian V. S. Hill

The sst1 locus has been identified in a mouse model to control resistance and susceptibility of Mycobacterium tuberculosis infection. Subsequent studies have now identified Ipr1 (intracellular pathogen resistance 1) to be the gene responsible. Ipr1 is encoded within the sst1 locus and is expressed in the tuberculosis lung lesions and macrophages of sst1-resistant, but not sst1-susceptible mice. We have therefore examined the closest human homologue of Ipr1, SP110, for its ability to control susceptibility to M. tuberculosis infection in humans. In a study of families from The Gambia we have identified three polymorphisms that are associated with disease. On examination of additional families from Guinea-Bissau and the Republic of Guinea, two of these associations were independently replicated. These variants are in strong linkage disequilibrium with each other and lie within a 31-kb block of low haplotypic diversity, suggesting that a polymorphism within this region has a role in genetic susceptibility to tuberculosis in humans.


Infection and Immunity | 2000

Human CD8+ T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia.

Steven M. Smith; Michèl R. Klein; Adam S. Malin; Jackson Sillah; Kris Huygen; Peter Andersen; Keith P. W. J. McAdam; Hazel M. Dockrell

ABSTRACT Intracellular flow cytometry analysis of perforin production by CD8+ T cells showed levels were greatly reduced in tuberculosis (TB) patients compared to healthy controls. Reduced cytotoxic-T-lymphocyte activity was also obtained with CD8+T cells from TB patients compared to healthy controls in The Gambia. A change in antigen recognition was noted between the two groups of donors: in addition to recognition of Ag85A and Ag85B, as seen in healthy donors, a prominent ESAT-6 response was found in TB patients.


Infection and Immunity | 2004

Immune Responses to Mycobacterial Antigens in the Gambian Population: Implications for Vaccines and Immunodiagnostic Test Design

Johan Vekemans; Martin O. C. Ota; Jackson Sillah; Katherine Fielding; Mark R. Alderson; Yasir A. W. Skeiky; Wilfried Dalemans; Keith P. W. J. McAdam; Christian Lienhardt; Arnaud Marchant

ABSTRACT Recombinant immunodominant mycobacterial antigens are needed for the development of new vaccines and immunodiagnostic tools for use against tuberculosis. Ubiquitous exposure to mycobacteria in tropical countries could influence vaccine-induced immunity and the specificity of tuberculosis immunodiagnosis. For this study conducted in The Gambia, cellular immune responses to recombinant mycobacterial antigens were characterized in Mycobacterium bovis BCG-vaccinated and nonvaccinated infants, adult community controls, household contacts, health care workers, and tuberculosis patients. Neonatal BCG vaccination induced gamma interferon (IFN-γ) responses to Mtb8.4, Mtb32-C, Mtb39A, Mtb9.9A, and Mtb32-N, but not CFP-10 (Mtb11) and α-crystallin (Mtb16). Exposure to Mycobacterium tuberculosis in household contacts and health care workers was associated with high responses to CFP-10 and α-crystallin. Generally, low IFN-γ responses were found in tuberculosis patients. These results suggest that Mtb8.4, Mtb32-C, Mtb39A, Mtb9.9A, and Mtb32-N may be used in a subunit vaccine to boost BCG-induced immunity. While CFP-10 and α-crystallin are promising candidates for the immunodiagnosis of M. tuberculosis infection or for vaccine use, disease-associated immunosuppression may prevent IFN-γ immunodiagnosis of more advanced tuberculosis.


Immunogenetics | 2003

Variants of the CD40 ligand gene are not associated with increased susceptibility to tuberculosis in West Africa

S J Campbell; Pardis C. Sabeti; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; Kebba Manneh; Ida Lisse; Giorgio Sirugo; Richard Bellamy; Steve Bennett; Peter Aaby; K.P.W.J. McAdam; Oumou Bah-Sow; Christian Lienhardt; Adrian V. S. Hill

Evidence for linkage between tuberculosis and human chromosomal region Xq26 has previously been described. The costimulatory molecule CD40 ligand, encoded by TNFSF5 and located at Xq26.3, is a promising positional candidate. Interactions between CD40 ligand and CD40 are involved in the development of humoral- and cell-mediated immunity, as well as the activation of macrophages, which are the primary host and effector cells for Mycobacterium tuberculosis. We hypothesised that common variation within TNFSF5 might affect susceptibility to tuberculosis disease and, thus, might be responsible for the observed linkage to Xq26. Sequencing 32 chromosomes from a Gambian population identified nine common polymorphisms within the coding, 3′ and 5′ regulatory sequences of the gene. Six single nucleotide polymorphisms (SNPs) and a 3′ microsatellite were genotyped in 121 tuberculosis patients and their available parents. No association with tuberculosis was detected for these variants using a transmission disequilibrium test, although one SNP at −726 showed some evidence of association in males. This finding, however, did not replicate in a separate case control study of over 1,200 West African individuals. We conclude that common genetic variation in TNFSF5 is not likely to affect tuberculosis susceptibility in West Africa and the linkage observed in this region is not due to variation in TNFSF5.


International Journal of Epidemiology | 2005

Investigation of the risk factors for tuberculosis: a case–control study in three countries in West Africa

Christian Lienhardt; Katherine Fielding; Jackson Sillah; Boubacar Bah; Per Gustafson; David K. Warndorff; M Palayew; I Lisse; Simon Donkor; S Diallo; Kebba Manneh; Richard A. Adegbola; Peter Aaby; Oumou Bah-Sow; Steve Bennett; K. P. W. J. Mcadam


American Journal of Respiratory and Critical Care Medicine | 2003

Risk factors for tuberculosis infection in sub-Saharan Africa: A contact study in The Gambia

Christian Lienhardt; Katherine Fielding; Jackson Sillah; Abdulaye Tunkara; Simon Donkor; Kebba Manneh; David K. Warndorff; Keith P. W. J. McAdam; Steve Bennett

Collaboration


Dive into the Jackson Sillah's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S J Campbell

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar

Boubacar Bah

BC Centre for Disease Control

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giorgio Sirugo

Medical Research Council

View shared research outputs
Top Co-Authors

Avatar

Peter Aaby

Statens Serum Institut

View shared research outputs
Researchain Logo
Decentralizing Knowledge